Parcourir par auteur "Papastergiopoulou, L."
Voici les éléments 1-3 de 3
-
Alternate day and daily administration of GnRH antagonist may prevent premature luteinization to a similar extent during FSH treatment
Messinis, I. E.; Loutradis, D.; Domali, E.; Kotsovassilis, C. P.; Papastergiopoulou, L.; Kallitsaris, A.; Drakakis, P.; Dafopoulos, K.; Milingos, S. (2005)BACKGROUND: This randomized controlled trial was designed to evaluate whether a GnRH antagonist given every other day could prevent premature luteinization in women undergoing IVF/ICSI treatment. METHODS: A total of 73 ... -
Effect of an OT antagonist on the control of the midcycle LH surge in women
Vanakara, P.; Dafopoulos, K.; Papastergiopoulou, L.; Kallitsaris, A.; Papageorgiou, I.; Messinis, I. E. (2009)P>Objective Data in women regarding the role of OT in LH secretion during the LH surge are conflicting. As in previous studies blood samples for LH measurements were taken infrequently, we re-examined this matter in women ... -
Oxytocin is not important for the control of gonadotrophin secretion in the late follicular phase of the cycle
Vanakara, P.; Dafopoulos, K.; Papastergiopoulou, L.; Kallitsaris, A.; Papageorgiou, I.; Messinis, I. E. (2007)Objective To study the role of oxytocin in basal and GnRH-induced gonadotrophin secretion in normal women. Design Normal women were studied in three cycles. When the diameter of the leading follicle was 15-16 mm, the women ...